[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the Saebo offering. Here's an excerpt describing the specifics of the change:

Campaign Extended for 90 days

When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

Saebo is committed to advancing the clinical profession through high-quality, evidence-based education. Here at Saebo, we believe knowledge is power. In August of 2020, we launched our online education site, Saebo Academy. Saebo Academy offers therapists and clinicians FREE self-study continuing education units (CEUs). These courses are nationally approved by the American Occupational Therapy Association (AOTA), a gold standard for educating and supporting rehabilitation professionals.

Saebo believes it is important to have the most effective and proven tools at a therapist’s disposal, and the CEUs help our users build a comprehensive treatment program for their clients.  Along with the Saebo Academy, therapists and clinicians can find clinical presentations, webinars, Saebo research, product information, training portals and videos, and clinical support, all within our website. We know that therapists and clinicians play a vital role in helping clients regain their ability to live independently and confidently. That is why we provide our clinicians easy, accessible resources and provide our therapists and clients with evidence-based products. There truly should be No Plateau In Sight.  

At 31 years old, Mimi Duffy quickly found herself in a fight for her life.

One morning, she awoke to what she believed was a common migraine headache. However, the ordinary soon turned into the extraordinary after her husband found her unresponsive on their bed.

A CT scan at the hospital showed substantial bleeding in the area between her brain and the thin tissue that covers it, otherwise known as the subarachnoid space. Unbeknownst to her loved ones, Mimi had suffered a major hemorrhagic stroke in her brain stem, paralyzing her entire right side.

She was immediately admitted to the ICU; she was in a coma and on a ventilator. Her prognosis was not good – doctors predicted to her husband, Chris, and her immediate family members that she would spend the rest of her life “locked-in,” a condition where the person is aware and awake but unable to move or verbally communicate.

That was more than two years ago. Today, Mimi finds herself immersed in therapy sessions and making strides toward becoming the independent woman she once was with the help of her SaeboFlex.

“The device not only gives me hope, but it also gives my once useless hand, purpose,” explains Mimi. “Thanks to the SaeboFlex, the range of motion in my right arm and shoulder are significantly improved. I can now do things I never thought I would be able to do again, such as move my right hand across my body to the left, turn my wrist over, and grasp and release objects with my hand.”

With the assistance of the SaeboFlex, Mimi is moving closer toward accomplishing her goal of returning to 100% mobility. Tasks she once found unattainable, now seem possible with a lot of practice, a concept that can be a challenge for a past salesperson who was constantly on the go and in a hurry.

“My ‘new’ body slows me down in life, but the SaeboFlex is helping me speed up my recovery,” said Mimi. “I would whole-heartedly recommend it to people like me. It’s helped my mind remember how it feels to use my hand and given me important options, such as working my fingers and providing me with the tools needed to perfect every movement I used to do on a daily basis.”

— Mimi Duffy, Stroke Survivor

Disclaimer: "This testimonial may not be representative of the experience of other customers and is no guarantee of future performance or success.”

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Saebo has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Saebo be on the lookout for an email that describes more about the disbursement process.

This campaign will continue to accept investments until its indicated closing date.

Thanks for funding the future.

-StartEngine

When we began our Start Engine Campaign, we felt like we had a really solid Sales and Marketing team in place, but knew we needed to add in a few areas. If you’ve read through our Campaign page, been following our “Updates” and looked over the Q&A in our “Comments” section, you’ll know that we are cash flow “break-even” from operations and that we are using the funds we are raising primarily to grow.

So, we wanted to give you a quick snapshot of how we are investing the money we’ve raised so far:

Talent

Any company is only as good as its staff, and we’ve added some good ones recently to continue our growth.

New Director of Digital Marketing and Ecommerce – After an exhaustive search reviewing over 400 candidates, we hired Mitch, who most recently helped grow a Consumer goods company from $5MM to 40MM in sales in 18 months and built a marketing department from 1 person to 11. Sounds like good preparation for what we need at Saebo!

New Regional Account Manager (RAM) – We promoted from within to this senior sales position responsible for selling Capital Equipment and Patient Products primarily to Hospitals.

New Territory Account Manager (TAR) – We were able to bring back a former employee into this important role facilitating Patient Product sales to consumers and therapists.

Two new Sales Admin Support staff – As our sales teams have gotten busier, they need more support to free them up to spend more time SELLING and less time moving paper and data. These are also great “feeder” positions to the TAR role as we continue to grow.

Marketing

Based on the ongoing success of our Digital Advertising and Marketing campaigns ( consistent ~5x ROAS) we have:

• Increased our US ad spend by 50%, with no apparent decline in ROAS. If this continues, we’ll ratchet it up another 50% in another month or so.
• Same in the UK, which continues to significantly outperform the prior year and this year’s budget.

Product

We’re also making significant investments in the Product Development and Sourcing areas:

• We are in beta test for a “new and improved” version of one of our most popular products. Feedback from customers so far has been “amazing.” . . . and the new version will ultimately cut our COGS in half, adding well over $100K to the bottom line in 2022 and opening up new distribution opportunities.
• We are still planning a summer/fall launch of our SaeboStim Spa (see Update #11 below) to treat neuropathy (nerve pain) common in stroke survivors, and also our first foray into the much larger diabetic neuropathy space. 
• We have increased our inventory of some of our harder-to-source products to minimize backorders (lost sales).

While all of this is a lot of investment, Don’t Worry that we’re trying to go too fast. Our Leadership team is very experienced in managing rapid growth with a focus on incremental profit from investments (ROI) and careful cash-flow management. We have more cash on hand and available to us now than at any time in the past few years – so plenty of “cushion” and fuel for continued growth!!!

Exciting news! Your investor perks have been delivered to your email! If you invested before April 21st and qualify for investor perks, please check your inbox for two emails from Saebo. We just wanted to say thank you again for investing in Saebo and supporting our mission. With your investment, we can help more people, treat more symptoms, and develop more solutions to assist those who need it the most. We are excited for you all to get your perks and starting using them! Please feel free to give us a call at (888) 349-1958 if you need any assistance using your coupon or store credit.

Well, now we know why Saebo’s Director of International Sales wanted in on the sales challenge! 

International Sales in April were up a whopping 59.7% vs. April 2020, helped by a $21K order from Qatar(!) and nice orders from Hong Kong and Australia.  However, David is telling us that international sales in May are going to be even better!!

The US also had great sales growth, up 52.8% vs. April 2020, on the strength of record US Direct-to-Patient sales (our fastest growing and most profitable category). 

The first couple weeks of May were also strong, so the US is going to give David a run for his money!

The UK is having a great year so far, beating the budget by 133%.  Unfortunately, while their April sales beat the budget, they were only about 1% ahead of April 2020.

Just a reminder, first prize is a Curry dinner at David’s favorite Indian restaurant in London (so everyone wins!!)  

Stay tuned for more updates as we continue to accelerate our business!!

The idea of a stroke can be frightening because it comes without warning and can cause a number of life-altering disabilities. Unfortunately, nearly 800,000 people will experience a new or recurrent stroke every year, and stroke is a leading cause of disability in the United States.

Here at Saebo, for the month of May, we will be sharing stroke warning signs, tips to prevent a stroke or second stroke, helpful recovery information, stroke rehabilitation products, and so much more with our audience on all our social media platforms.

With a support team, the right rehabilitation plan and products, and a positive attitude, strokes can be beatable. Rehabilitation is key to achieving and praising all the small victories during recovery.

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the Saebo offering. Here's an excerpt describing the specifics of the change:

Saebo has extended their campaign and added 2020 financials

When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

International sales are already about 25% of Saebo’s total sales and growing rapidly.  After a very successful Q1, Saebo’s International Director of Sales, David de Magtige, wants to get in on the Q2 sales competition between the US and UK. Check out these statistics and watch David’s video below  to learn more about Saebo’s Q1 International sales, a “teaser” for Q2 results, and a bonus of finding out where David’s favorite curry (Indian) restaurant is in London!

-  Q1 sales in 2021 were up 44% from 2020 

-  March sales were up a fantastic 51% compared to last March

When Saebo UK’s Managing Director heard the recent update on our record US Patient Product and Ecommerce sales for Q1, he couldn’t resist bragging (in his restrained, British way) about the UK’s record Q1 results as well, . . .AND .. .  challenging the US to a sales competition.  Well, . . . . GAME ON!!!  Watch below.

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Saebo has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Saebo be on the lookout for an email that describes more about the disbursement process.

This campaign will continue to accept investments until its indicated closing date.

Thanks for funding the future.

-StartEngine

WOW!!  

What a great start to the new year!  Saebo set the following sales records in March and the First Quarter:

• Q1 2021 US Direct-To-Patient (DTP) sales were up 27% vs Q1 2020 (which were up 18% vs.2019)!
• March 2021 US DTP sales were up 69% vs. March 2020 (which were up 7% vs. 2019)!
• March 2021 was a record sales month for the award-winning SaeboGlove!
• March 2021 was a record sales month for our new SaeboStimPRO!
• For the first time in our history, in March we sold over 1,000 products direct to US patients!

With more new products coming later this year, with new strategic relationships under negotiation, and with new international distributors interested in selling our products, we’ve never been more optimistic about our future!

Saebo is pleased to introduce our soon-to-be-launched SaeboStim Spa. The SaeboStim Spa helps patients suffering from neurological injuries such as stroke as well as pain from peripheral neuropathy due to diabetes and other nerve-related disorders. This breakthrough home technology is FDA-approved and backed by years of electrical stimulation research. Please be sure to stay tuned for more details regarding this exciting new product!

Here is what one of our test customers had to say about the new SaeboStim Spa. 

"I have been using the spa every day for the last ten days. I am walking about 2 miles a day with minimal pain. Thank you again for providing help with my feet issue." — Larry *

* This testimonial may not be representative of the experience of other customers and are not a guarantee of future performance or success.

Well, it’s been a year since the COVID pandemic began.  It’s a cliché’ to say everything changed . . . . but some things didn’t, like the growth in Saebo’s e-commerce sales.  Our e-commerce channel was already growing at high double-digit percentage rates pre-pandemic, and after a brief decline when lockdowns were first implemented last March, our e-commerce sales came back stronger than ever!

- Despite rehab facilities being closed

- Stroke survivors still wanted to regain function

- So they increasingly turned to Saebo’s affordable, effective products for home rehab.

- . . . and always with a 30-day Money Back Guarantee!

That’s a 600% increase in e-commerce sales in just the last three years! Our e-commerce growth strategy is clearly working, and a significant portion of the money we raise will go to new product launches and additional marketing to increase these sales even faster!

Kim Hook is an Occupational Therapist who has used Saebo’s products in her practice for ten years. Learn why she is such a fan of Saebo’s products and why she continues to believe in the company.

Disclaimer: "This testimonial may not be representative of the experience of other customers and is no guarantee of future performance or success.”

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Saebo has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Saebo be on the lookout for an email that describes more about the disbursement process.

This campaign will continue to accept investments until its indicated closing date.

Thanks for funding the future.

-StartEngine

Saebo’s preliminary 4th quarter sales results are in, and despite the COVID-19 pandemic, our North American Patient orders are up a remarkable 13% versus Q4 prior year. This despite the fact that many of the rehabilitation facilities that refer Patient Products to us were closed, or on a very limited schedule for much of the year.  Further, online orders of Patient Products through our shopping cart were up a whopping 53% for Q4 compared to Q4 2019, and up more than 50% for the full year, demonstrating the scalable nature of Saebo’s business model, and the continued strong demand for our Patient Products. 

Saebo further reports that International orders, including Saebo’s wholly-owned UK subsidiary, were up 8% in Q4 2020 vs. Q4 2019. This is significant because many of Saebo’s large international markets (e.g., Germany, Italy, Benelux, UK, etc.) were also seriously impacted by COVID-19 shutdowns and restrictions in 2020.

“These significant increases, especially under the circumstances, highlight the company’s successful pivot in the face of COVID-19 related challenges to the US healthcare systems,” said Saebo’s President, Henry Hoffman. “By promoting and delivering our products directly to patients for in-home use, we’ve been able to help our customers around the world continue their recoveries at home while increasing the most important and fastest-growing segments of our business."

Check out this 30-second video of a UK client making remarkable gains over the holiday break with the SaeboGlove and SaeboMAS. The patient started with little hand movement. Watch how these products transformed his recovery.

The cutting-edge SaeboGlove supports a survivor’s affected hand while they move throughout their day. The SaeboGlove assists the patient with normal hand activities like grasping household items and rebuilds muscular strength in the process. The proprietary tension system extends the fingers and thumb after grasping. The SaeboGlove is based on the latest advances in neurorehabilitation research about the brain’s ability to “reprogram” itself through mass practice, task-oriented arm training. 

The SaeboMAS, a zero-gravity arm support system, takes the weight off the shoulder and allows the arm to achieve the range of motion necessary for standard tasks and exercises. This, in turn, strengthens the muscles around the arm that would have otherwise gone unused. The SaeboMAS can assist with performing the prescribed repetitive motions that fight against joint pain, muscle spasticity, and weakness.

Thank you to our supporters! We reached our minimum raise in just 12 hours and now have over 130 new investors in Saebo! Here at Saebo, we are dedicated to bringing accessible, affordable, mobility solutions to all. We stay committed to “leaving no patient behind” and set out to create products that every patient can benefit from. If you have any questions about Saebo or our campaign, please feel free to leave us a comment below. Thank you!

Congratulations to Jeffrey Neal Isaac, Ph.D., our first Stroke Survivor to invest in Saebo. We want to thank all of our early investors and followers so far. Our vision is to help every patient, and there are about 79 million stroke survivors out there who could benefit from our solutions, just like our friend Jeffery did!

Disclaimer: "This testimonial may not be representative of the experience of other customers and is no guarantee of future performance or success.”